相关实验视频

Updated: Jun 21, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

洞察地幔细胞淋巴瘤病理生物学,诊断和治疗使用基于网络和药物重定位的方法

Georgia Orfanoudaki^1,2, Konstantina Psatha^1,2,3, Michalis Aivaliotis^1,2,4,5

¹Functional Proteomics and Systems Biology (FunPATh), Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Balkan Center, GR-54124 Thessaloniki, Greece.

International journal of molecular sciences

|July 13, 2024

概括

这项研究揭示了基因表达变化如何驱动侵略性地幔细胞淋巴瘤 (MCL) 的进展. 结果确定了关键蛋白质,并建议用于治疗这种B细胞非霍奇金淋巴瘤 (NHL) 的新药组合.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

薄膜细胞淋巴瘤 (MCL) 是一种具有有限治疗选择的侵袭性B细胞非霍奇金淋巴瘤 (NHL).
瘤间异质性和分子复杂性阻碍了MCL的早期诊断和有效的治疗策略.

研究的目的:

通过转录基因数据分析,研究推动MCL进展的分子机制.
为了确定潜在的诊断生物标志物,药物点,以及MCL的组合疗法.

主要方法:

来自明确定义的MCL阶段的公共转录组数据的多方面的分析.
集成基于网络的方法,包括路径丰富和共同表达模块分析.
药物重定位和组合预测算法的应用.

主要成果:

证明了一种"蝶效应",即最初的基因表达变化迅速升级为在侵略性MCL中广泛的细胞过程放松调节.
识别了MCL各个阶段的共同共同表达模块,突出了VEGFA和SPARC蛋白在疾病进展中的作用.
为潜在的治疗干预而提出的特定药物组合.

结论:

该研究提供了一种基于网络的方法,以了解MCL病理生物学,并确定新的治疗策略.
维格法和SPARC与MCL进展有关,这表明它们作为生物标志物或治疗点的潜力.
建议对已识别的药物组合进行进一步验证,以确定其在MCL治疗中的临床影响.

关键词:

生物标志物生物标志物差异化表达的差异化表达的差异化表达药物重用是为了改变药物的用途.地毯细胞淋巴瘤非霍奇金淋巴瘤的非霍奇金淋巴瘤.阶段阶段的阶段.

更多相关视频

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...